Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v7-EN | Version v4-EN | |
|---|---|---|
| Language | English | English |
| Date Updated (Changed) | Updated to: 2026-01-01 | Was: 2025-12-31 |
| Drug Identification Number | 02499894 | 02499894 |
| Brand name | NAT-OSELTAMIVIR | NAT-OSELTAMIVIR |
| Common or Proper name | OSELTAMIVIR | OSELTAMIVIR |
| Company Name | NATCO PHARMA (CANADA) INC | NATCO PHARMA (CANADA) INC |
| Ingredients | OSELTAMIVIR | OSELTAMIVIR |
| Strength(s) | 6MG | 6MG |
| Dosage form(s) | POWDER FOR SUSPENSION | POWDER FOR SUSPENSION |
| Route of administration | ORAL | ORAL |
| Packaging size | 1 BOTTLE | 1 BOTTLE |
| Additional packaging sizes | ||
| ATC code | J05AH | J05AH |
| ATC description | DIRECT ACTING ANTIVIRALS | DIRECT ACTING ANTIVIRALS |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date (Changed) | Updated to: | Was: 2026-01-23 |
| Actual start date | 2025-12-31 | 2025-12-31 |
| Estimated end date | Unknown | Unknown |
| Actual end date | ||
| Shortage status (Changed) | Updated to: Actual shortage | Was: Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Due to increase in demand there might be a shortage for NAT-Oseltamivir Suspension. NAT-OSELTAMIVIR (oseltamivir phosphate) Capsules 75 mg remain available for compounding a suspension if NAT-Oseltamivir Oral Suspension is not available. Refer to the product monograph for compounding instructions. | Due to increase in demand there might be a shortage for NAT-Oseltamivir Suspension. NAT-OSELTAMIVIR (oseltamivir phosphate) Capsules 75 mg remain available for compounding a suspension if NAT-Oseltamivir Oral Suspension is not available. Refer to the product monograph for compounding instructions. |
| Health Canada comments |